Valuation: DarioHealth Corp.

Market Cap 73.25M 63.47M 59.47M 54.24M 102M 6.99B 104M 699M 273M 3.5B 275M 269M 11.67B P/E 2026 *
-2.54x
P/E 2027 * -3.03x
Enterprise Value 73.25M 63.47M 59.47M 54.24M 102M 6.99B 104M 699M 273M 3.5B 275M 269M 11.67B EV / Sales 2026 *
3.38x
EV / Sales 2027 * 2.3x
Free-Float
84.06%
Yield 2026 *
-
Yield 2027 * -
1 day-2.48%
1 week-2.35%
Current month+2.89%
1 month+3.60%
3 months-13.82%
6 months-33.51%
Current year-34.27%
1 week 6.75
Extreme 6.75
8.2
1 month 6.07
Extreme 6.07
8.2
Current year 5.84
Extreme 5.8445
13.64
1 year 5.84
Extreme 5.8445
17.74
3 years 5.84
Extreme 5.8445
69.8
5 years 5.84
Extreme 5.8445
387.8
10 years 5.84
Extreme 5.8445
1,880
Manager TitleAgeSince
Corporate Officer/Principal - 11/08/2011
Chief Executive Officer 52 09/08/2013
Director of Finance/CFO 38 01/01/2021
Director TitleAgeSince
Chairman 52 23/11/2014
Director/Board Member 69 12/11/2013
Director/Board Member 57 23/11/2014
Date Insider Type Main position Quantity % Market Cap.
23/07/26 Buy

Director

14,430 0.1973%
11/09/25 Free

Director

20,000 0.0440%
11/09/25 Free

Director

20,000 0.0440%
Change 5-day change 1-year change 3-year change Capi.($)
-2.48%-2.35%-12.68%-88.16% 73.25M
+1.08%+4.92%-15.35%+5.32% 192B
+0.09%+5.55%-1.43%+8.76% 116B
-5.90%-0.96%+8.65%+67.67% 59.95B
+2.11%+4.26%+33.94%+64.61% 54.64B
+1.20%+7.57%-5.84%-34.97% 50B
+1.42%+9.85%+13.26%-18.70% 34.26B
+1.31%-3.18% - - 31.15B
+0.26%+0.36%+46.85%-10.75% 24.79B
+0.85%+13.34%-6.26%+23.46% 24.07B
Average -0.01%+3.58%+6.79%+1.91% 58.7B
Weighted average by Cap. +0.26%+4.27%+0.78%+13.54%

Financials

2026 *2027 *
Net sales 21.66M 18.76M 17.58M 16.04M 30.15M 2.07B 30.61M 207M 80.83M 1.03B 81.31M 79.55M 3.45B 31.82M 27.57M 25.83M 23.56M 44.29M 3.03B 44.97M 304M 119M 1.52B 119M 117M 5.07B
Net income -32.49M -28.15M -26.37M -24.05M -45.22M -3.1B -45.92M -310M -121M -1.55B -122M -119M -5.17B -20.49M -17.75M -16.63M -15.17M -28.52M -1.95B -28.96M -196M -76.46M -978M -76.92M -75.25M -3.26B
Net Debt - -
Logo DarioHealth Corp.
DarioHealth Corp. is a global digital therapeutics (DTx) company delivering personalized evidence-based interventions that are driven by data analytics, software, and personalized coaching. The Company’s platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health. Its digital therapeutic platform has been designed with a user-first strategy, focusing on the user’s needs and user experience and satisfaction. Dario Blood Glucose Monitoring Starter Kit is a pocket-sized smartphone glucometer that manages diabetes in one ultra-compact device. Dario Blood Pressure Monitoring System is a blood pressure monitoring system used to measure blood pressure, which allows it to store all its user readings in the Dario App. The Dario mobile app is a complete, cloud-based solution for personal chronic condition management.
Employees
163
Date Price Change Volume
12/08/26 $7.480 -2.48% 10,204
11/08/26 $7.670 +0.13% 54,980
10/08/26 $7.660 +4.93% 24,337
07/08/26 $7.300 -5.78% 29,574
06/08/26 $7.748 +1.15% 3,964
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
7.480USD
Average target price
14.50USD
Spread / Average Target
+93.85%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. DRIO Stock